Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03057548 · ClinicalTrials.gov registry record · NA
Comparison of Pulmonary Vein Ablation With or Without Left Atrial Posterior Wall Ablation for Persistent AF (PIVoTAL)
A NA study of Persistent Atrial Fibrillation and Atrial Fibrillation Chronic, sponsored by Arash Aryana, MD.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
- 2
- Study locations
NCT03057548 is a NA study of Persistent Atrial Fibrillation and Atrial Fibrillation Chronic that has completed, run by Arash Aryana, MD. The registered enrollment target is 110 participants, below the 1,253-participant average among 15 other Persistent Atrial Fibrillation trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT03057548, a NA study of Persistent Atrial Fibrillation and Atrial Fibrillation Chronic, has completed, sponsored by Arash Aryana, MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study it to learn whether pulmonary vein isolation (PVI) along with ablation of the posterior left atrial wall (PLAW) will reduce the likelihood of atrial fibrillation (AF) recurrence in patients with persistent or long-standing persistent AF one year after an ablation procedure in comparison to a PVI ablation procedure, alone. The investigator hypothesizes that the combination of PVI plus PLAW isolation will result in a reduction in recurrence of atrial arrhythmias at one year after ablation.
Conditions Studied
Interventions
- PROCEDURE Cryo or Radiofrequency (RF) Ablation only of Pulmonary Veins
- PROCEDURE Cryo or RF Ablation of Pulmonary Veins plus Ablation of the PLAW
Study Locations (2)
California
- Mercy General Hospital and Dignity Health Heart and Vascular Institute - Sacramento
Other
- Heart Center, Japan Red Cross Yokohama-city Bay Hospital - Yokohama
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2017-02-24 |
| Est. Completion | 2020-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03057548
The ClinicalTrials.gov registry entry for NCT03057548 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,253-participant average among 15 other Persistent Atrial Fibrillation trials with a reported enrollment target (91% lower). The listed sponsor is Arash Aryana, MD, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Persistent Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which Cryo or Radiofrequency (RF) Ablation only of Pulmonary Veins is the first listed.
NCT03057548 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Other.
Frequently Asked Questions
What is clinical trial NCT03057548 about?
NCT03057548 is a clinical study titled "Comparison of Pulmonary Vein Ablation With or Without Left Atrial Posterior Wall Ablation for Persistent AF (PIVoTAL)". The purpose of this study it to learn whether pulmonary vein isolation (PVI) along with ablation of the posterior left atrial wall (PLAW) will reduce the likelihood of atrial fibrillation (AF) recurrence in patients with persistent or long-standing persistent AF one year after an ablation procedure ...
What is the current status of trial NCT03057548?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2017-02-24. Estimated completion is 2020-05-31.
What conditions does trial NCT03057548 study?
This clinical trial studies the following conditions: Persistent Atrial Fibrillation, Atrial Fibrillation Chronic.
What interventions are being tested in trial NCT03057548?
The interventions under investigation include: Cryo or Radiofrequency (RF) Ablation only of Pulmonary Veins (PROCEDURE), Cryo or RF Ablation of Pulmonary Veins plus Ablation of the PLAW (PROCEDURE).
Who is sponsoring clinical trial NCT03057548?
This trial is sponsored by Arash Aryana, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03057548 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Persistent Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Endocardial Mapping With the CoreMap EP Mapping System
RECRUITING · NA
-
ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
RECRUITING · NA
-
ARIADNE Clinical Trial
RECRUITING · NA
-
Medtronic Terminate AF Study
RECRUITING · NA
-
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
RECRUITING · NA
-
Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Persistent Atrial Fibrillation
All registered trials for this condition
Atrial Fibrillation Chronic
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.